Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphism.
暂无分享,去创建一个
S. Yano | K. Fukuda | S. Takeuchi | A. Takagi | Hiroyuki Takahashi | S. Arai | H. Konishi | Azusa Tanimoto | S. Ong | A. Nishiyama | S. Tiong Ong | Akimitsu Takagi